Investigation of FOL-005 on Clinical Safety and Effect on Hair Growth

Inclusion Criteria: * Healthy male, aged 18-45 years * Clinically visible terminal hair growth on thighs Exclusion Criteria: * Damaged skin in or around test sites * History of any acute (e.g. acute infections) or chronic illness or known skin cancer that might confound the results of the trial * History or clinical signs of keloids or hypertrophic scars * Immunological disorders such as alopecia areata, and systemic lupus erythematosus * Current or within 2 weeks prior to first dosing use of vasodilating drugs (e.g. Pentoxifyllin, nitroglycerine) or anticoagulating drugs (e.g. heparine, cumarines, new oral anticoagulants) * Current or within 3 months prior to first dosing use of anti-inflammatory medication, corticosteroids or immunosuppressive drugs taken for more than 2 consecutive weeks * Current or within 3 months prior to first dosing use of medication with hair growth modifying properties like minoxidil, diazoxid, cyclosporine, antiandrogens * Current or within 12 months prior to first dosing intake of anabolics or 5-alpha reductase inhibitors * Current or within one week prior to first dosing use of any topical drugs on the legs